Inventor · disambiguated record
Baptiste Manteau
Also filed as: MANTEAU BAPTISTE
6 granted patents·5 pending applications·9 citations·filing 2015–2024
73Inventor score
Top patents by PatentIndex Score
11 records- 0182US11008323B2Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2016·Granted May 18, 2021·5 cites·13 claims
- 0276US10017521B2Chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptorsPREXTON THERAPEUTICS SA·Filed 2015·Granted Jul 10, 2018·3 cites·15 claims
- 0374US10442818B2Chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptorsPREXTON THERAPEUTICS SA·Filed 2018·Granted Oct 15, 2019·1 cites·5 claims
- 0467US2025049814A15-azaindazole derivatives as adenosine receptor antagonistsMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 0553US12194051B25-azaindazole derivatives as adenosine receptor antagonistsMERCK PATENT GMBH·Filed 2019·Granted Jan 14, 2025·0 cites·15 claims
- 0652US2020024285A1Novel chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptorsPREXTON THERAPEUTICS SA·Filed 2019·Application pending·0 cites
- 0746US2019152979A1Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group ii metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0844US2022089609A1Substituted quinazolinone derivatives and their use as positive allosteric modulators of mglur4DOMAIN THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0939US2021380606A15-azaindazole derivatives as adenosine receptor antagonistsMERCK PATENT GMBH·Filed 2019·Application pending·0 cites
- 1038US10221179B2Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2015·Granted Mar 5, 2019·0 cites·21 claims
- 1131US11472806B2Substituted heterocyclic compounds as allosteric modulators of group II metabotropic glutamate receptorsDOMAIN THERAPEUTICS·Filed 2018·Granted Oct 18, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Baptiste Manteau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →